Welcome to our dedicated page for Tomi Environmental Solutions I news (Ticker: TOMZ), a resource for investors and traders seeking the latest updates and insights on Tomi Environmental Solutions I stock.
TOMI Environmental Solutions, Inc. reports developments tied to disinfection and decontamination products built around SteraMist iHP and Binary Ionization Technology. Company news commonly covers biocidal regulatory approvals, SteraMist applications in healthcare, life sciences, food safety, commercial facilities, transportation and remediation settings, and product categories such as BIT Solution consumables, integrated systems, mobile equipment and iHP Corporate Service offerings.
Updates also include operating and financial results, customer and service activity, training and application protocols, shareholder voting matters, governance topics, capital-structure disclosures and material agreements. TOMI's recurring business themes include the installed base for SteraMist delivery systems, consumable BIT Solution demand, engineered decontamination systems and professional decontamination services.
TOMI Environmental Solutions (NASDAQ: TOMZ) has announced the purchase of SteraMist disinfection systems by the U.S. Department of Health and Human Services for its Biosafety Level 3 laboratory in Africa. This order includes two SteraPak systems and two Select Surface Units, expanding the NIH's deployment of SteraMist to 30 machines across 11 divisions. SteraMist's technology features a low concentration of hydrogen peroxide, enabling effective disinfection while minimizing equipment corrosion. The COO stated their commitment to supporting NIH's mission with innovative solutions.
TOMI Environmental Solutions (NASDAQ: TOMZ) announced a significant $280,000 purchase order from Critical Scientific Solutions for three modified SteraMist Environment Systems. These systems will be utilized by a leading influenza vaccine company for decontamination of cleanrooms and ductwork. The partnership has proven effective since its inception, gaining traction in Australia and New Zealand. TOMI's COO expressed optimism regarding future opportunities in the Life Science sector, emphasizing strong demand for their custom engineered systems.
TOMI Environmental Solutions, Inc. (NASDAQ: TOMZ) has received a purchase order for an iHP Custom Engineered System from Avid Bioservices for a new viral vector manufacturing facility in Costa Mesa, California. This system will be implemented in four GMP manufacturing suites and will include eleven applicators. SteraMist was selected due to its rapid decontamination capabilities and low hydrogen peroxide content. The installation is expected to be completed in the first half of 2023, marking a significant step in TOMI's collaboration with Avid, emphasizing the effectiveness of SteraMist technology in the growing cell and gene therapy market.
TOMI Environmental Solutions, Inc. (NASDAQ: TOMZ) announced the expanding use of its SteraMist decontamination products by a major U.S. pharmaceutical company. Initially adopted five years ago for small spaces, the company has progressively ordered more units, including mobile systems and full-room foggers, totaling around $1 million in expected revenue. Starting in 2023, these systems are projected to generate an annual revenue of approximately $250,000. TOMI's reputation as a disinfection standard continues to grow in the life sciences sector amid increasing investments in safety.
TOMI Environmental Solutions, Inc. (NASDAQ: TOMZ) specializes in disinfection technology and will participate in the H.C. Wainwright 24th Annual Global Investment Conference from September 12-14, 2022. Dr. Halden Shane, CEO, will present virtually, with the pre-recorded presentation available on September 12. Investors can register for access via the provided link. TOMI's innovative products utilize Binary Ionization Technology to provide effective disinfection solutions across various sectors, including healthcare, education, and military facilities.
TOMI Environmental Solutions, Inc. (NASDAQ: TOMZ) reported its financial results for Q2 and the first half of 2022, highlighting a 6% revenue growth year-over-year. The company saw a significant 35% increase in customer orders and secured $5.6 million in orders from Fortune 500 clients. While Q2 revenues were flat at $1.458 million, operating loss decreased by 28% to $863,000 due to effective expense management. The gross margin remained strong at 63.2%. TOMI expects revenue recognition from key orders throughout the year, driven by demand for its Custom Engineered Systems.
TOMI Environmental Solutions, Inc. (NASDAQ: TOMZ) will report its second-quarter results for the period ending June 30, 2022, on August 15, 2022, post-market close. A conference call is scheduled for 4:30 p.m. ET on the same day, accessible by phone or via live webcast. TOMI specializes in disinfection and decontamination solutions, leveraging its Binary Ionization Technology (BIT™) to service various sectors, including healthcare and food processing. Replay options for the teleconference and webcast will be available afterward.
TOMI Environmental Solutions (NASDAQ: TOMZ) announced significant advancements for its SteraMist disinfection technology in the food safety industry during the International Association for Food Production Annual Meeting. The SteraMist iHP technology effectively preserves the shelf life of produce and eliminates harmful pathogens, as supported by recent studies. SteraMist demonstrated a dramatic reduction of fungal growth in a large-scale vertical farm, showcasing its efficacy against pathogens causing substantial crop losses. TOMI aims for SteraMist to become a standard in food safety disinfection.
TOMI Environmental Solutions, Inc. (NASDAQ: TOMZ) has received multiple purchase orders for its iHP Custom Engineered System (CES), highlighting increased global interest in its decontamination technology. The orders include an implementation in four lab rooms at a major biologics development company, expected to generate approximately $730,000 in Q4 2022 revenue. Additionally, a biotechnology firm has ordered a system for a new decontamination room, projecting another $150,000 in revenue. TOMI's SteraMist technology is recognized for its speed, efficiency, and material compatibility.
TOMI Environmental Solutions, Inc. (NASDAQ:TOMZ) announced its inclusion on the EPA's List Q for disinfectants effective against emerging viral pathogens, including Monkeypox and SARS-CoV-2. This recognition positions TOMI's SteraMist product line as a reliable solution for disinfection during outbreak scenarios. The BIT solution, highlighted for its efficacy and safety, utilizes ionized Hydrogen Peroxide technology to provide effective decontamination. CEO Dr. Halden Shane expressed satisfaction with the EPA recognition, reinforcing the credibility and environmental safety of TOMI's products.